Comparing Sprintec vs Vienva
| Sprintec (ethinyl estradiol / norgestimate) | Vienva (ethinyl estradiol / levonorgestrel) |
|
|---|
| Sprintec (ethinyl estradiol / norgestimate) | Vienva (ethinyl estradiol / levonorgestrel) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Abnormal Uterine Bleeding, Endometriosis, Ovarian Cysts, Birth Control, Gonadotropin Inhibition. Sprintec may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Birth Control. Vienva may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||
| More about Sprintec (ethinyl estradiol / norgestimate) | More about Vienva (ethinyl estradiol / levonorgestrel) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Sprintec has an average rating of 5.5 out of 10 from a total of 1297 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 36% reported a negative effect. |
Vienva has an average rating of 4.7 out of 10 from a total of 344 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 49% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Lower cost generic approved | Lower cost generic approved | ||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Sprintec prices |
View all Vienva prices |
||||||||||||||||
| Dosage Forms Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other ethinyl estradiol / norgestimate brands include: Estarylla, Femynor, Mili, Mono-Linyah, Nymyo, Previfem, Tri Femynor, Tri-Estarylla, Tri-Linyah, Tri-Lo-Estarylla, Tri-Lo-Linyah, Tri-Lo-Marzia, Tri-Lo-Mili, Tri-Lo-Sprintec, Tri-Mili, Tri-Nymyo, Tri-Previfem, Tri-Sprintec, Tri-VyLibra, Tri-Vylibra Lo, VyLibra View more | Other ethinyl estradiol / levonorgestrel brands include: Afirmelle, Altavera, Amethia, Amethia Lo, Amethyst, Ashlyna, Aubra, Aubra EQ, Aviane, Ayuna, Balcoltra, Camrese, CamreseLo, Cerinta, Chateal, Chateal EQ, Daysee, Delyla, Dolishale, Elifemme, Enpresse, Falmina, Fayosim, Iclevia, Introvale, Jaimiess, Jolessa, Joyeaux, Kurvelo, Larissia, Lessina, Levlen, Levonest, Levora, Lillow, Lo Simpesse, LoJaimiess, LoSeasonique, Lutera, Marlissa, Minzoya, Myzilra, Orsythia, Portia, Quartette, Rivelsa, Seasonale, Seasonique, Setlakin, Simpesse, Sronyx, Trivora, Twirla, Tyblume View more | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
N/A |
45 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 469 drugs are known to interact with Sprintec:
|
A total of 471 drugs are known to interact with Vienva:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
|
||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
May 21, 2015 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.